HEADER TRANSFERASE 30-NOV-15 5FPF TITLE CRYSTAL STRUCTURE OF HUMAN TANKYRASE 2 IN COMPLEX WITH TA-91 COMPND MOL_ID: 1; COMPND 2 MOLECULE: TANKYRASE-2; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: C-TERMINAL FRAGMENT, RESIDUES 946-1113; COMPND 5 SYNONYM: TANK2, ADP-RIBOSYLTRANSFERASE DIPHTHERIA TOXIN-LIKE 6, ARTD COMPND 6 6, POLY ADP-RIBOSE POLYMERASE 5B, TNKS-2, TRF1-INTERACTING ANKYRIN - COMPND 7 RELATED ADP-RIBOSE POLYMERASE 2, TANKYRASE II, TANKYRASE-LIKE COMPND 8 PROTEIN, TANKYRASE-RELATED PROTEIN; COMPND 9 ENGINEERED: YES; COMPND 10 MOL_ID: 2; COMPND 11 MOLECULE: TANKYRASE-2; COMPND 12 CHAIN: C, D; COMPND 13 FRAGMENT: C-TERMINAL FRAGMENT, RESIDUES 1115-1162; COMPND 14 SYNONYM: TANK2, ADP-RIBOSYLTRANSFERASE DIPHTHERIA TOXIN-LIKE 6, ARTD COMPND 15 6, POLY ADP-RIBOSE POLYMERASE 5B, TNKS-2, TRF1-INTERACTING ANKYRIN - COMPND 16 RELATED ADP-RIBOSE POLYMERASE 2, TANKYRASE II, TANKYRASE-LIKE COMPND 17 PROTEIN, TANKYRASE-RELATED PROTEIN; COMPND 18 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_VARIANT: ROSETTA 2; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PNIC28-BSA4; SOURCE 10 MOL_ID: 2; SOURCE 11 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 12 ORGANISM_COMMON: HUMAN; SOURCE 13 ORGANISM_TAXID: 9606; SOURCE 14 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 15 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 16 EXPRESSION_SYSTEM_VARIANT: ROSETTA 2; SOURCE 17 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 18 EXPRESSION_SYSTEM_PLASMID: PNIC28-BSA4 KEYWDS TRANSFERASE, PROTEIN-LIGAND COMPLEX, DIPHTHERIA TOXIN LIKE FOLD, ADP- KEYWDS 2 RIBOSYLATION, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR T.HAIKARAINEN,L.LEHTIO REVDAT 3 10-JAN-24 5FPF 1 REMARK REVDAT 2 27-SEP-17 5FPF 1 REMARK ATOM REVDAT 1 14-DEC-16 5FPF 0 JRNL AUTH A.NATHUBHAI,T.HAIKARAINEN,P.C.HAYWARD,S.MUNOZ-DESCALZO, JRNL AUTH 2 D.TOSH,M.D.LLOYD,L.LEHTIO,M.D.THREADGILL JRNL TITL DESIGN, SYNTHESIS AND EVALUATION OF NOVEL DUAL- BINDING JRNL TITL 2 INHIBITORS OF THE TANKYRASES AND WNT SIGNALLING. JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.42 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 94.2 REMARK 3 NUMBER OF REFLECTIONS : 14325 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.217 REMARK 3 R VALUE (WORKING SET) : 0.213 REMARK 3 FREE R VALUE : 0.272 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 718 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 29.4171 - 4.4419 0.92 2793 148 0.1583 0.1977 REMARK 3 2 4.4419 - 3.5276 0.94 2698 142 0.1836 0.2720 REMARK 3 3 3.5276 - 3.0822 0.95 2743 145 0.2514 0.3048 REMARK 3 4 3.0822 - 2.8007 0.94 2651 139 0.3019 0.3584 REMARK 3 5 2.8007 - 2.6000 0.96 2722 144 0.3428 0.3860 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.370 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 31.470 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 46.71 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.009 3464 REMARK 3 ANGLE : 1.097 4666 REMARK 3 CHIRALITY : 0.040 456 REMARK 3 PLANARITY : 0.005 612 REMARK 3 DIHEDRAL : 16.511 1266 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5FPF COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 30-NOV-15. REMARK 100 THE DEPOSITION ID IS D_1290065678. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 31-AUG-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID29 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.99987 REMARK 200 MONOCHROMATOR : LIQUID NITROGEN COOLED CHANNEL REMARK 200 -CUT SILICON MONOCHROMATOR REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 14363 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.600 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.3 REMARK 200 DATA REDUNDANCY : 7.100 REMARK 200 R MERGE (I) : 0.30000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.67 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.2 REMARK 200 DATA REDUNDANCY IN SHELL : 7.10 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.040 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 3U9Y REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.16 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M BICINE PH 9.0, 16% PEG6000, PH REMARK 280 8.5 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 20.80000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 74.52500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 38.04000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 74.52500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 20.80000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 38.04000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6810 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 10470 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -35.3 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6780 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 10360 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -34.2 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 923 REMARK 465 HIS A 924 REMARK 465 HIS A 925 REMARK 465 HIS A 926 REMARK 465 HIS A 927 REMARK 465 HIS A 928 REMARK 465 HIS A 929 REMARK 465 SER A 930 REMARK 465 SER A 931 REMARK 465 GLY A 932 REMARK 465 VAL A 933 REMARK 465 ASP A 934 REMARK 465 LEU A 935 REMARK 465 GLY A 936 REMARK 465 THR A 937 REMARK 465 GLU A 938 REMARK 465 ASN A 939 REMARK 465 LEU A 940 REMARK 465 TYR A 941 REMARK 465 PHE A 942 REMARK 465 GLN A 943 REMARK 465 SER A 944 REMARK 465 MET A 945 REMARK 465 LEU A 946 REMARK 465 ASN A 947 REMARK 465 THR A 948 REMARK 465 SER A 949 REMARK 465 GLY A 950 REMARK 465 SER A 951 REMARK 465 SER A 1111 REMARK 465 ALA A 1112 REMARK 465 MET A 1113 REMARK 465 MET B 923 REMARK 465 HIS B 924 REMARK 465 HIS B 925 REMARK 465 HIS B 926 REMARK 465 HIS B 927 REMARK 465 HIS B 928 REMARK 465 HIS B 929 REMARK 465 SER B 930 REMARK 465 SER B 931 REMARK 465 GLY B 932 REMARK 465 VAL B 933 REMARK 465 ASP B 934 REMARK 465 LEU B 935 REMARK 465 GLY B 936 REMARK 465 THR B 937 REMARK 465 GLU B 938 REMARK 465 ASN B 939 REMARK 465 LEU B 940 REMARK 465 TYR B 941 REMARK 465 PHE B 942 REMARK 465 GLN B 943 REMARK 465 SER B 944 REMARK 465 MET B 945 REMARK 465 LEU B 946 REMARK 465 ASN B 947 REMARK 465 THR B 948 REMARK 465 SER B 949 REMARK 465 GLY B 950 REMARK 465 SER B 951 REMARK 465 SER B 1111 REMARK 465 ALA B 1112 REMARK 465 MET B 1113 REMARK 465 MET C 1115 REMARK 465 GLY C 1162 REMARK 465 MET D 1115 REMARK 465 GLY D 1162 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A1019 5.44 -66.67 REMARK 500 ASN A1020 40.47 -146.50 REMARK 500 TYR A1050 84.38 -68.22 REMARK 500 ARG B 980 31.46 -87.25 REMARK 500 ASN B1020 32.39 -140.05 REMARK 500 PRO B1034 15.64 -65.28 REMARK 500 TYR B1050 95.66 -58.49 REMARK 500 ALA B1057 82.63 -67.13 REMARK 500 ARG C1128 64.53 -168.47 REMARK 500 SER D1124 -178.51 -173.00 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN B 2111 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 2111 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 5ZI B 2112 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 5ZI A 2112 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5FPG RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN TANKYRASE 2 IN COMPLEX WITH TA-92 DBREF 5FPF A 946 1113 UNP Q9H2K2 TNKS2_HUMAN 946 1113 DBREF 5FPF B 946 1113 UNP Q9H2K2 TNKS2_HUMAN 946 1113 DBREF 5FPF C 1115 1162 UNP Q9H2K2 TNKS2_HUMAN 1115 1162 DBREF 5FPF D 1115 1162 UNP Q9H2K2 TNKS2_HUMAN 1115 1162 SEQADV 5FPF MET A 923 UNP Q9H2K2 EXPRESSION TAG SEQADV 5FPF HIS A 924 UNP Q9H2K2 EXPRESSION TAG SEQADV 5FPF HIS A 925 UNP Q9H2K2 EXPRESSION TAG SEQADV 5FPF HIS A 926 UNP Q9H2K2 EXPRESSION TAG SEQADV 5FPF HIS A 927 UNP Q9H2K2 EXPRESSION TAG SEQADV 5FPF HIS A 928 UNP Q9H2K2 EXPRESSION TAG SEQADV 5FPF HIS A 929 UNP Q9H2K2 EXPRESSION TAG SEQADV 5FPF SER A 930 UNP Q9H2K2 EXPRESSION TAG SEQADV 5FPF SER A 931 UNP Q9H2K2 EXPRESSION TAG SEQADV 5FPF GLY A 932 UNP Q9H2K2 EXPRESSION TAG SEQADV 5FPF VAL A 933 UNP Q9H2K2 EXPRESSION TAG SEQADV 5FPF ASP A 934 UNP Q9H2K2 EXPRESSION TAG SEQADV 5FPF LEU A 935 UNP Q9H2K2 EXPRESSION TAG SEQADV 5FPF GLY A 936 UNP Q9H2K2 EXPRESSION TAG SEQADV 5FPF THR A 937 UNP Q9H2K2 EXPRESSION TAG SEQADV 5FPF GLU A 938 UNP Q9H2K2 EXPRESSION TAG SEQADV 5FPF ASN A 939 UNP Q9H2K2 EXPRESSION TAG SEQADV 5FPF LEU A 940 UNP Q9H2K2 EXPRESSION TAG SEQADV 5FPF TYR A 941 UNP Q9H2K2 EXPRESSION TAG SEQADV 5FPF PHE A 942 UNP Q9H2K2 EXPRESSION TAG SEQADV 5FPF GLN A 943 UNP Q9H2K2 EXPRESSION TAG SEQADV 5FPF SER A 944 UNP Q9H2K2 EXPRESSION TAG SEQADV 5FPF MET A 945 UNP Q9H2K2 EXPRESSION TAG SEQADV 5FPF MET B 923 UNP Q9H2K2 EXPRESSION TAG SEQADV 5FPF HIS B 924 UNP Q9H2K2 EXPRESSION TAG SEQADV 5FPF HIS B 925 UNP Q9H2K2 EXPRESSION TAG SEQADV 5FPF HIS B 926 UNP Q9H2K2 EXPRESSION TAG SEQADV 5FPF HIS B 927 UNP Q9H2K2 EXPRESSION TAG SEQADV 5FPF HIS B 928 UNP Q9H2K2 EXPRESSION TAG SEQADV 5FPF HIS B 929 UNP Q9H2K2 EXPRESSION TAG SEQADV 5FPF SER B 930 UNP Q9H2K2 EXPRESSION TAG SEQADV 5FPF SER B 931 UNP Q9H2K2 EXPRESSION TAG SEQADV 5FPF GLY B 932 UNP Q9H2K2 EXPRESSION TAG SEQADV 5FPF VAL B 933 UNP Q9H2K2 EXPRESSION TAG SEQADV 5FPF ASP B 934 UNP Q9H2K2 EXPRESSION TAG SEQADV 5FPF LEU B 935 UNP Q9H2K2 EXPRESSION TAG SEQADV 5FPF GLY B 936 UNP Q9H2K2 EXPRESSION TAG SEQADV 5FPF THR B 937 UNP Q9H2K2 EXPRESSION TAG SEQADV 5FPF GLU B 938 UNP Q9H2K2 EXPRESSION TAG SEQADV 5FPF ASN B 939 UNP Q9H2K2 EXPRESSION TAG SEQADV 5FPF LEU B 940 UNP Q9H2K2 EXPRESSION TAG SEQADV 5FPF TYR B 941 UNP Q9H2K2 EXPRESSION TAG SEQADV 5FPF PHE B 942 UNP Q9H2K2 EXPRESSION TAG SEQADV 5FPF GLN B 943 UNP Q9H2K2 EXPRESSION TAG SEQADV 5FPF SER B 944 UNP Q9H2K2 EXPRESSION TAG SEQADV 5FPF MET B 945 UNP Q9H2K2 EXPRESSION TAG SEQRES 1 A 191 MET HIS HIS HIS HIS HIS HIS SER SER GLY VAL ASP LEU SEQRES 2 A 191 GLY THR GLU ASN LEU TYR PHE GLN SER MET LEU ASN THR SEQRES 3 A 191 SER GLY SER GLY THR ILE LEU ILE ASP LEU SER PRO ASP SEQRES 4 A 191 ASP LYS GLU PHE GLN SER VAL GLU GLU GLU MET GLN SER SEQRES 5 A 191 THR VAL ARG GLU HIS ARG ASP GLY GLY HIS ALA GLY GLY SEQRES 6 A 191 ILE PHE ASN ARG TYR ASN ILE LEU LYS ILE GLN LYS VAL SEQRES 7 A 191 CYS ASN LYS LYS LEU TRP GLU ARG TYR THR HIS ARG ARG SEQRES 8 A 191 LYS GLU VAL SER GLU GLU ASN HIS ASN HIS ALA ASN GLU SEQRES 9 A 191 ARG MET LEU PHE HIS GLY SER PRO PHE VAL ASN ALA ILE SEQRES 10 A 191 ILE HIS LYS GLY PHE ASP GLU ARG HIS ALA TYR ILE GLY SEQRES 11 A 191 GLY MET PHE GLY ALA GLY ILE TYR PHE ALA GLU ASN SER SEQRES 12 A 191 SER LYS SER ASN GLN TYR VAL TYR GLY ILE GLY GLY GLY SEQRES 13 A 191 THR GLY CYS PRO VAL HIS LYS ASP ARG SER CYS TYR ILE SEQRES 14 A 191 CYS HIS ARG GLN LEU LEU PHE CYS ARG VAL THR LEU GLY SEQRES 15 A 191 LYS SER PHE LEU GLN PHE SER ALA MET SEQRES 1 B 191 MET HIS HIS HIS HIS HIS HIS SER SER GLY VAL ASP LEU SEQRES 2 B 191 GLY THR GLU ASN LEU TYR PHE GLN SER MET LEU ASN THR SEQRES 3 B 191 SER GLY SER GLY THR ILE LEU ILE ASP LEU SER PRO ASP SEQRES 4 B 191 ASP LYS GLU PHE GLN SER VAL GLU GLU GLU MET GLN SER SEQRES 5 B 191 THR VAL ARG GLU HIS ARG ASP GLY GLY HIS ALA GLY GLY SEQRES 6 B 191 ILE PHE ASN ARG TYR ASN ILE LEU LYS ILE GLN LYS VAL SEQRES 7 B 191 CYS ASN LYS LYS LEU TRP GLU ARG TYR THR HIS ARG ARG SEQRES 8 B 191 LYS GLU VAL SER GLU GLU ASN HIS ASN HIS ALA ASN GLU SEQRES 9 B 191 ARG MET LEU PHE HIS GLY SER PRO PHE VAL ASN ALA ILE SEQRES 10 B 191 ILE HIS LYS GLY PHE ASP GLU ARG HIS ALA TYR ILE GLY SEQRES 11 B 191 GLY MET PHE GLY ALA GLY ILE TYR PHE ALA GLU ASN SER SEQRES 12 B 191 SER LYS SER ASN GLN TYR VAL TYR GLY ILE GLY GLY GLY SEQRES 13 B 191 THR GLY CYS PRO VAL HIS LYS ASP ARG SER CYS TYR ILE SEQRES 14 B 191 CYS HIS ARG GLN LEU LEU PHE CYS ARG VAL THR LEU GLY SEQRES 15 B 191 LYS SER PHE LEU GLN PHE SER ALA MET SEQRES 1 C 48 MET ALA HIS SER PRO PRO GLY HIS HIS SER VAL THR GLY SEQRES 2 C 48 ARG PRO SER VAL ASN GLY LEU ALA LEU ALA GLU TYR VAL SEQRES 3 C 48 ILE TYR ARG GLY GLU GLN ALA TYR PRO GLU TYR LEU ILE SEQRES 4 C 48 THR TYR GLN ILE MET ARG PRO GLU GLY SEQRES 1 D 48 MET ALA HIS SER PRO PRO GLY HIS HIS SER VAL THR GLY SEQRES 2 D 48 ARG PRO SER VAL ASN GLY LEU ALA LEU ALA GLU TYR VAL SEQRES 3 D 48 ILE TYR ARG GLY GLU GLN ALA TYR PRO GLU TYR LEU ILE SEQRES 4 D 48 THR TYR GLN ILE MET ARG PRO GLU GLY HET ZN A2111 1 HET 5ZI A2112 56 HET ZN B2111 1 HET 5ZI B2112 56 HETNAM ZN ZINC ION HETNAM 5ZI 4-[3-(4-OXO-3,4-DIHYDROQUINAZOLIN-2- YL)PROPANAMIDO]-N- HETNAM 2 5ZI (QUINOLIN-8-YL)BENZAMIDE FORMUL 5 ZN 2(ZN 2+) FORMUL 6 5ZI 2(C27 H21 N5 O3) FORMUL 9 HOH *12(H2 O) HELIX 1 1 ASP A 962 THR A 975 1 14 HELIX 2 2 ASN A 1002 GLU A 1019 1 18 HELIX 3 3 PHE A 1035 GLY A 1043 1 9 HELIX 4 4 ASP A 1045 ALA A 1049 5 5 HELIX 5 5 ASN A 1064 ASN A 1069 1 6 HELIX 6 6 GLN A 1070 VAL A 1072 5 3 HELIX 7 7 GLY A 1074 GLY A 1078 5 5 HELIX 8 8 ASP B 962 THR B 975 1 14 HELIX 9 9 ASN B 1002 GLU B 1019 1 18 HELIX 10 10 PHE B 1035 GLY B 1043 1 9 HELIX 11 11 ASP B 1045 ALA B 1049 5 5 HELIX 12 12 ASN B 1064 GLN B 1070 1 7 HELIX 13 13 GLY B 1074 GLY B 1078 5 5 HELIX 14 14 ARG C 1143 GLU C 1145 5 3 HELIX 15 15 ARG D 1143 GLU D 1145 5 3 SHEET 1 AA 5 ILE A 954 ASP A 957 0 SHEET 2 AA 5 TYR A 992 CYS A1001 -1 O LYS A 999 N ILE A 956 SHEET 3 AA 5 ALA C1147 ILE C1157 -1 O GLU C1150 N VAL A1000 SHEET 4 AA 5 ARG A1094 THR A1102 -1 O ARG A1094 N TYR C1155 SHEET 5 AA 5 GLU A1026 HIS A1031 -1 O ARG A1027 N VAL A1101 SHEET 1 AB 4 ILE A1059 ALA A1062 0 SHEET 2 AB 4 GLU C1138 ILE C1141 -1 O TYR C1139 N PHE A1061 SHEET 3 AB 4 SER C1124 GLY C1127 -1 O VAL C1125 N VAL C1140 SHEET 4 AB 4 SER A1106 LEU A1108 1 O PHE A1107 N THR C1126 SHEET 1 BA 5 ILE B 954 ASP B 957 0 SHEET 2 BA 5 TYR B 992 CYS B1001 -1 O LYS B 999 N ILE B 956 SHEET 3 BA 5 ALA D1147 ILE D1157 -1 O GLU D1150 N VAL B1000 SHEET 4 BA 5 ARG B1094 THR B1102 -1 O ARG B1094 N TYR D1155 SHEET 5 BA 5 GLU B1026 HIS B1031 -1 O ARG B1027 N VAL B1101 SHEET 1 BB 4 ILE B1059 ALA B1062 0 SHEET 2 BB 4 GLU D1138 ILE D1141 -1 O TYR D1139 N PHE B1061 SHEET 3 BB 4 SER D1124 GLY D1127 -1 O VAL D1125 N VAL D1140 SHEET 4 BB 4 SER B1106 LEU B1108 1 O PHE B1107 N THR D1126 SHEET 1 CA 2 SER C1130 VAL C1131 0 SHEET 2 CA 2 LEU C1134 ALA C1135 -1 O LEU C1134 N VAL C1131 SHEET 1 DA 2 SER D1130 VAL D1131 0 SHEET 2 DA 2 LEU D1134 ALA D1135 -1 O LEU D1134 N VAL D1131 SITE 1 AC1 4 CYS B1081 HIS B1084 CYS B1089 CYS B1092 SITE 1 AC2 4 CYS A1081 HIS A1084 CYS A1089 CYS A1092 SITE 1 AC3 13 HIS B1031 GLY B1032 ALA B1038 ILE B1039 SITE 2 AC3 13 GLY B1043 PHE B1044 ASP B1045 HIS B1048 SITE 3 AC3 13 TYR B1050 TYR B1060 PHE B1061 SER B1068 SITE 4 AC3 13 TYR B1071 SITE 1 AC4 14 HIS A1031 GLY A1032 PHE A1035 ALA A1038 SITE 2 AC4 14 ILE A1039 GLY A1043 PHE A1044 ASP A1045 SITE 3 AC4 14 HIS A1048 TYR A1050 TYR A1060 SER A1068 SITE 4 AC4 14 TYR A1071 GLU C1138 CRYST1 41.600 76.080 149.050 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.024038 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013144 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006709 0.00000